๐ Catheter Precision $VTAK rockets +42% premarket on cardiac mapping platform expansion
Small-cap med-tech Catheter Precision (VTAK) is gapping up over 42% this morning on volume roughly 7x its historical norm after announcing expanded adoption of its VIVO System โ a non-invasive 3D cardiac mapping tool used before electrophysiology procedures. VTAK is one of the biggest premarket gainers in the market today. Not financial advice. Could this gap hold into the open, or is this a classic gap-and-trap?
โก 31 buzzing
245 views
๐ 0 subscribed